- Report
- May 2025
- 150 Pages
Global
From €4407EUR$4,850USD£3,788GBP
- Report
- October 2022
- 205 Pages
Asia Pacific
From €3135EUR$3,450USD£2,695GBP
- Report
- September 2025
- 142 Pages
Global
From €3500EUR$4,126USD£3,114GBP
- Report
- September 2025
- 87 Pages
Global
From €3500EUR$4,126USD£3,114GBP
- Report
- August 2025
- 98 Pages
Global
From €3500EUR$4,126USD£3,114GBP
- Report
- May 2025
- 90 Pages
Global
From €3500EUR$4,126USD£3,114GBP
- Report
- June 2025
- 109 Pages
Global
From €3135EUR$3,450USD£2,695GBP
- Report
- June 2025
- 97 Pages
Asia Pacific
From €3589EUR$3,950USD£3,085GBP
- Report
- June 2025
- 81 Pages
From €3135EUR$3,450USD£2,695GBP
- Report
- June 2025
- 198 Pages
Global
From €4498EUR$4,950USD£3,866GBP
- Report
- June 2025
- 81 Pages
Africa, Middle East
From €3135EUR$3,450USD£2,695GBP
- Report
- June 2025
- 100 Pages
Europe
From €3589EUR$3,950USD£3,085GBP
- Report
- June 2025
- 89 Pages
North America
From €3135EUR$3,450USD£2,695GBP
- Report
- May 2025
- 132 Pages
Global
From €4407EUR$4,850USD£3,788GBP
- Report
- April 2025
- 225 Pages
Global
From €4089EUR$4,500USD£3,515GBP
- Report
- March 2025
- 145 Pages
Global
From €4407EUR$4,850USD£3,788GBP
- Report
- March 2025
- 260 Pages
Middle East
From €2635EUR$2,900USD£2,265GBP
- Report
- March 2025
- 260 Pages
Africa
From €2635EUR$2,900USD£2,265GBP
- Report
- March 2025
- 210 Pages
Latin America
From €2635EUR$2,900USD£2,265GBP
- Report
- March 2025
- 840 Pages
Asia Pacific
From €2635EUR$2,900USD£2,265GBP

The Antidiabetic market is a subset of Endocrine and Metabolic Disorders Drugs, which are used to treat a variety of conditions related to hormones and metabolism. Antidiabetic drugs are used to treat diabetes, a chronic condition in which the body does not produce or properly use insulin. These drugs can help control blood sugar levels, reduce the risk of complications, and improve quality of life. Common antidiabetic drugs include insulin, sulfonylureas, biguanides, thiazolidinediones, and meglitinides.
Some companies in the Antidiabetic market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and Boehringer Ingelheim. These companies produce a variety of antidiabetic drugs, including insulin, oral medications, and combination products. Show Less Read more